JUN 24, 2015 09:00 AM PDT

Solaris™ - A novel open-air fluorescence imaging system for image-guided surgery applications

10 45 11877

  • R&D Leader, Life Sciences Technology, PerkinElmer
      Wael Yared currently leads research and product development activities for PerkinElmer's Life Sciences & Technology business at the Company's new Center for Personalized Health Innovation. Dr. Yared also leads the Company's clinical translation programs for in vivo diagnostics in collaboration with strategic partners. Prior to joining PerkinElmer, Dr. Yared was Chief Technology Officer for VisEn Medical, acquired by PerkinElmer in August 2010, where he led the development of fluorescence molecular tomography and VisEn's molecular agent portfolio. He holds a Ph.D. in Engineering from Massachusetts Institute of Technology.
    • Director, Applied Biology, PerkinElmer
        Jeffrey Peterson received his Ph.D. in Immunology and Neuroscience from Northwestern University where his research was focused on autoimmune diseases including multiple sclerosis and Type I diabetes. After finishing his degree, Dr. Peterson worked as a scientist at Boehringer Ingelheim and Abbott Bioresearch where he led development of novel drugs, therapies, and biomarkers. Dr. Peterson has been leading research efforts in fluorescence imaging for the past 9 years at VisEn Medical and then PerkinElmer, developing novel imaging agents and applications in preclinical research models.

      Date: Wednesday, June 24th, 2015
      Time: 09:00AM PDT, 12:00PM EDT, 4:00PM GMT

      Solaris™ is a new open-air fluorescence imaging system developed by PerkinElmer, enabling translational in vivo preclinical imaging in small and large animals. Solaris is a high impact research tool with the flexibility to be utilized in various invasive, intra-operative and superficial non-invasive image-guided fluorescence imaging applications. Solaris integrates into current surgical workflows, allowing the researcher to visualize optical data live, hands-free and in a fully lit space.

      In this webinar Dr. Wael Yared will outline the technological advantages of the instrument. Solaris is engineered to provide real-time visualization of optical imaging data, in vivo, in an ambient light. Key technological features enabling integration into existing workflows include ambient light rejection, spectral unmixing and the inclusion of four fluorescence channels covering a wide spectrum of fluorescent agents and markers. Dr. Jeffrey Peterson will demonstrate the feature capabilities in a variety of preclinical disease models. Image-guided tumor detection and resection, as well as lymph node mapping and cell tracking applications will be highlighted.

      Show Resources
      Loading Comments...